Literature DB >> 8609552

Long-term results of peripheral nerve stimulation for reflex sympathetic dystrophy.

S J Hassenbusch1, M Stanton-Hicks, D Schoppa, J G Walsh, E C Covington.   

Abstract

This prospective, consecutive series describes peripheral nerve stimulation (PNS) for treatment of severe reflex sympathetic dystrophy (RSD) or complex regional pain syndrome, in patients with symptoms entirely or mainly in the distribution of one major peripheral nerve. Plate-type electrodes were placed surgically on affected nerves and tested for 2 to 4 days. Programmable generators were implanted if 50% or more pain reduction and objective improvement in physical changes were achieved. Patients were followed for 2 to 4 years and a disinterested third-party interviewer performed final patient evaluations. Of 32 patients tested, 30 (94%) underwent permanent PNS placement. Long-term good or fair relief was experienced in 19 (63%) of 30 patients. In successfully treated patients, allodynic and spontaneous pain was reduced on a scale of 10 from 8.3 +/- 0.3 preimplantation to 3.5 +/- 0.4 (mean +/- standard error of the mean) at latest follow up (p<0.001). Changes in vasomotor tone and patient activity levels were markedly improved but motor weakness and trophic changes showed less improvement. Six (20%) of the 30 patients undergoing PNS placement returned to part-time or full-time work after being unemployed prestimulator implantation. Initial involvement of more than one major peripheral nerve correlated with a poor or no relief rating (p<0.01). Operative modifications that minimize technical complications are described. This study indicates that PNS can provide good relief for RSD that is limited to the distribution of one major nerve.

Entities:  

Mesh:

Year:  1996        PMID: 8609552     DOI: 10.3171/jns.1996.84.3.0415

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  25 in total

Review 1.  Complex regional pain syndromes.

Authors:  R Baron; G Wasner
Journal:  Curr Pain Headache Rep       Date:  2001-04

2.  Complex Regional Pain Syndrome-Reflex Sympathetic Dystrophy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-11       Impact factor: 3.598

3.  Peripheral nerve stimulation for trigeminal neuropathic pain.

Authors:  David A Stidd; Adam L Wuollet; Kirk Bowden; Theodore Price; Amol Patwardhan; Steve Barker; Martin E Weinand; Jeffrey Annabi; Emil Annabi
Journal:  Pain Physician       Date:  2012 Jan-Feb       Impact factor: 4.965

Review 4.  [Complex regional pain syndrome: A current review].

Authors:  C Maihöfner
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

5.  Peripheral nerve stimulation for the treatment of postamputation pain--a case report.

Authors:  Richard L Rauck; Leonardo Kapural; Steven P Cohen; James M North; Christopher A Gilmore; Rosemary H Zang; Joseph W Boggs
Journal:  Pain Pract       Date:  2012-05-02       Impact factor: 3.183

Review 6.  Peripheral nerve stimulation for neuropathic pain.

Authors:  Konstantin V Slavin
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

7.  Median Nerve Stimulation in a Patient with Complex Regional Pain Syndrome Type II.

Authors:  Ik-Chan Jeon; Min-Su Kim; Seong-Ho Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30

8.  Conservative therapy for Complex Regional Pain Syndrome Type I in a paediatric patient: a case study.

Authors:  Randy W Beck
Journal:  J Can Chiropr Assoc       Date:  2009

Review 9.  [Recent trends in understanding and therapy of complex regional pain syndromes].

Authors:  G Wasner; J Schattschneider; A Binder; D Siebrecht; C Maier; R Baron
Journal:  Anaesthesist       Date:  2003-10       Impact factor: 1.041

10.  Peripheral Nerve Stimulation in Pain Management: A Systematic Review.

Authors:  Jijun Xu; Zhuo Sun; Jiang Wu; Maunak Rana; Joshua Garza; Alyssa C Zhu; Krishnan V Chakravarthy; Alaa Abd-Elsayed; Ellen Rosenquist; Hersimren Basi; Paul Christo; Jianguo Cheng
Journal:  Pain Physician       Date:  2021-03       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.